Familial hypercholesterolemia and lipoprotein (a): a Gordian knot in cardiovascular prevention

AD Koutsogianni, PS Adamidis, F Barkas… - Metabolites, 2022 - mdpi.com
Familial hypercholesterolemia (FH) is the most frequent genetic disorder resulting in
increased low-density lipoprotein cholesterol (LDL-C) levels from childhood, leading to …

Molecular markers of diabetic retinopathy: potential screening tool of the future?

P Pusparajah, LH Lee, K Abdul Kadir - Frontiers in physiology, 2016 - frontiersin.org
Diabetic retinopathy (DR) is among the leading causes of new onset blindness in adults.
Effective treatment may delay the onset and progression of this disease provided it is …

Effects of Lipid-Modifying and Other Drugs on Lipoprotein (a) Levels—Potent Clinical Implications

AD Koutsogianni, G Liamis, E Liberopoulos… - Pharmaceuticals, 2023 - mdpi.com
The past few years have shown an ongoing interest in lipoprotein (a)(Lp (a)), a lipid
molecule that has been proven to have atherogenic, thrombogenic, and inflammatory …

Homocysteine serum levels in diabetic patients with non proliferative, proliferative and without retinopathy

G Malaguarnera, C Gagliano… - BioMed research …, 2014 - Wiley Online Library
Homocysteine has been associated with extracellular matrix changes. The diabetic
retinopathy is a neurovascular complication of diabetes mellitus and it is the leading cause …

Oxidized phospholipids and lipoprotein (a): An update

AD Koutsogianni, E Liberopoulos… - European Journal of …, 2022 - Wiley Online Library
Over the past few years, there has been an undiminished interest in lipoprotein (a)[Lp (a)]
and oxidized phospholipids (OxPLs), mainly carried on this lipoprotein. Elevated Lp (a) has …

Lipoprotein (a) and apolipoproteins as predictors for diabetic retinopathy and its severity in adults with type 2 diabetes: a case-cohort study

F Moosaie, RM Davatgari, FD Firouzabadi… - Canadian Journal of …, 2020 - Elsevier
Objectives Our aim in this study was to assess the relationship between serum lipoprotein
(a)[Lp (a)] and apolipoproteins and the risk of developing diabetic retinopathy (DR). Methods …

Folate status in type 2 diabetic patients with and without retinopathy

G Malaguarnera, C Gagliano, S Salomone… - Clinical …, 2015 - Taylor & Francis
Background Folate deficiency is associated with cardiovascular disease, megaloblastic
anemia, and with hyperhomocysteinemia. This study has been undertaken to investigate the …

[HTML][HTML] Ginkgo biloba extract in ophthalmic and systemic disease, with a focus on normal-tension glaucoma

M Labkovich, EB Jacobs, S Bhargava… - Asia-Pacific journal of …, 2020 - Elsevier
Glaucoma is a neurodegenerative eye disease that results in retinal ganglion cell loss and
ultimately loss of vision. Elevated intraocular pressure (IOP) is the most common known risk …

Lipoprotein (a) as a predictor of diabetic retinopathy in patients with type 2 diabetes: A systematic review

MS Gholami Chahkand… - … & Vascular Disease …, 2023 - journals.sagepub.com
Background Lipoprotein a (LP (a)), an LDL-like lipoprotein, known as a risk factor for
cardiovascular diseases, has a controversial association with diabetic retinopathy in patients …

Lipid variability and risk of microvascular complications in patients with diabetes: a systematic review and meta-analysis

MA Karimi, A Vaezi, A Ansari, I Archin, K Dadgar… - BMC Endocrine …, 2024 - Springer
Background and aims The current systematic review aimed to elucidate the effects of lipid
variability on microvascular complication risk in diabetic patients. The lipid components …